Popular digital weight loss app, Noom (NOOM) undercuts Novo Nordisk's Wegovy by offering quarter-dose packs at $119 for the ...

Technological innovation and personalized care are transforming Hims & Hers into a proactive health platform. Read why I ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

The telehealth and wellness stock tanked more than 12% Aug. 5, a day after posting mixed Q2 earnings. More importantly, Bank ...

The Microdose GLP-1Rx Program will offer low-dose GLP-1 prescriptions combined with behavioral coaching, clinical monitoring and medication management.

Hims & Hers Health showed a sharper-than-expected revenue hiccup in Q2, sending the stock down. Click here to find out why ...

European giant Novo Nordisk vowed to lower prices for its popular weight-loss drug to reach more U.S. customers.

Liberals promised to ‘significantly reduce’ wait times for pharmaceuticals, which it acknowledged were longer than in other ...

The tech trade is proving resilient, even unstoppable, while the firms that gained by helping people lose weight are ...